Specialty Pharmaceutical Company with a Focus in Pain and Addiction

Filing date Description Form Filing Group Filer View

Quarterly report which provides a continuing view of a company's financial position

10-Q
Quarterly Filings
0001193125-18-159340.pdf 0001193125-18-159340.rtf 0001193125-18-159340.xls EX-101.INS - XBRL INSTANCE DOCUMENT View HTML

Initial filing by director officer or owner of more than ten percent.

3
3,4,5
Cukier Herm 0000899243-18-011852.pdf 0000899243-18-011852.rtf View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
Cukier Herm 0000899243-18-011861.pdf 0000899243-18-011861.rtf View HTML

Report of unscheduled material events or corporate event

8-K
Current Reports
0001193125-18-156071.pdf 0001193125-18-156071.rtf 0001193125-18-156071.xls View HTML

Additional proxy soliciting materials - definitive

DEFA14A
Proxy Filings
0001193125-18-150960.pdf 0001193125-18-150960.rtf 0001193125-18-150960.xls View HTML

Report of unscheduled material events or corporate event

8-K
Current Reports
0001193125-18-150959.pdf 0001193125-18-150959.rtf 0001193125-18-150959.xls View HTML

An amendment to a SC 13D filing

SC 13D/A
3,4,5
0000921895-18-001510.pdf 0000921895-18-001510.rtf 0000921895-18-001510.xls View HTML

CT ORDER

CT ORDER
Other
9999999997-18-004970.pdf 9999999997-18-004970.rtf View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
Sirgo Mark A 0000899243-18-010157.pdf 0000899243-18-010157.rtf View HTML

Filing by person(s) reporting owned shares of common stock in a public company >5%

SC 13D
3,4,5
0000921895-18-001241.pdf 0000921895-18-001241.rtf 0000921895-18-001241.xls View HTML

Copyright Morningstar

Investor Presentation

There are no items to display.

Get the latest details on our products and services.

SIGN UP